Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
About this Journal
Privacy Statement
Open access policy
Cost of publication
Guides for authors
Current
Archives
Editorial Board
Submissions
Archive 2018-2006
Contact
Register
Login
Home
/
Search
Search
Search articles for
Advanced filters
Published After
Year
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
Year
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search
Search Results
Found 217 items.
INTERPLAY OF LNCRNAS, METABOLIC CELL DEATH, AND IMMUNE MICROENVIRONMENT IN GENITOURINARY MALIGNANCIES
V. Gordiiuk, L. Shevchenko, D. Todoryshyn, V. Kashuba, O. Mankovska
143-155
07.10.2025
DOI:
https://doi.org/10.15407/exp-oncology.2025.02.143
CLINICAL SIGNIFICANCE OF SALIVARY MIR-21, -155, AND -375 IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF ORAL CAVITY
O. BURTYN, T. BORIKUN, O. ROSSYLNA, A. KOPCHAK, О. KRAVETS
139-145
09.10.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.02.139
Quality of Life Assessed by the Questionnaire MOS SF-36 in Bladder Cancer Patients Depending on the Method of Surgical Treatment
P. YAKOVLEV, V. KUTS, S. ZEMSKOV, R. VERESHCHAKO
351-357
12.12.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.04.351
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
Y.V. Dumanskiy, O.V. Bondar, E.A. Stoliarchuk
176-178
05.06.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13303
Human microbiota and effectiveness of cancer chemotherapy
Yu.V. Shvets, N.Yu. Lukianova, V.F. Chekhun
82-93
01.06.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14611
LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY
A. Loboda, O. Movchan, I. Smolanka (Sr), Yu. Dumanskyi, A. Lyashenko, O. Ivankova, I. Dosenko
356-360
30.12.2025
DOI:
https://doi.org/10.15407/exp-oncology.2025.03.356
Modern Landscape of Innovative Technologies in Optimizing the Quality of Life of Cancer Patients
V. CHEKHUN
281-288
12.12.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.04.281
COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER
L.V. Garmanchuk, P.G. Yakovlev, G.V. Ostrovska, Yu.A. Stupak, O.V. Skachkova, O.I. Gorbach, Yu.V. Stepanov
130-136
26.06.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.01.130
EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN
O. Pridko, T. Borikun, O. Rossylna, M. Rishko, A.V. Rusyn
295-299
09.03.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19152
Improving Patients’ Quality of Life After Surgical Treatment of Primary Malignant Bone Tumors Using a Training 3D Model
O. DROBOTUN, V. PROTSENKO, N. TERNOVYY
341-344
12.12.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.04.341
ASSESSMENT OF CIRCULATING miRNA LEVELS IN BREAST CANCER PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY
О. Harashchenko
451-456
12.12.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.04.451
Features of recurrence of endometrioid type endometrial cancer of I stage
O.M. Movchan, V.S. Svintsitskiy, N.P. Tsip, S.V. Nespryadko, O.I. Bublіieva, N.P. Iurchenko
365-369
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.17052
PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER
Marija Jelic, Aljosa Mandic, Slobodan Maricic, Biljana Bozin, Nebojsa Kladar, Jan Sudji, Branislava Srdjenovic Conic
231-241
11.10.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.231
Volodymyr Oleksiyovych SHLYAKHOVENKO
537-538
12.12.2023
Tumor microenvironment and metabolic factors: contribution to gastric cancer
L. Bubnovskaya, D. Osinsky
2-10
01.06.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-1.14056
APPENDICULAR MUCINOUS CYSTADENOMA AND CYSTOADENOSARCOMA IN GYNECOLOGICAL PRACTICE. CLINICAL CASES AND LITERATURE REVIEW
V.О. SKLYAROVА, V.V. MAKSYMYUK, R.A. CHAJKIVSKYJ, O.V. PRYKUPENKO, O.M. NEPYIVODA, T.YU. ROZHANSKYI, YU.T. MARTYN, V.R. CHAJKIVSKA
108-114
11.07.2025
DOI:
https://doi.org/10.15407/exp-oncology.2025.01.108
EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA
Wani Zahoor, Arshad A. Pandith, Syed Nisar, Iqbal Qasim, Menka Surana, Farooq A. Ganie, Usma Manzoor, Sajad H. Arif, Shayaq Ul Abeer Rasool, Adil Lateef, Parveen Shah, Rashid A. Bhat
203-210
11.10.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.203
201 - 217 of 217 items
<<
<
4
5
6
7
8
9
Language
Українська
English
Make a Submission
Make a Submission